
TIANYU BIO-TECHNOLOGY CO.,LTD. — Investor Relations & Filings
TIANYU BIO-TECHNOLOGY CO.,LTD. specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. The company focuses on therapeutic areas such as cardiovascular health, diabetes management, and anti-viral treatments. Its core product portfolio includes various sartan-based intermediates and other complex organic synthesis products. TIANYU BIO-TECHNOLOGY emphasizes rigorous quality management systems and adheres to international regulatory standards to ensure product safety and efficacy. By leveraging advanced chemical synthesis technologies and a robust R&D infrastructure, the company provides customized manufacturing solutions and high-quality chemical components to global pharmaceutical partners. Its operations are characterized by a commitment to technical innovation and process optimization in the synthesis of complex molecules.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于召开2024年第一次临时股东大会的通知 | 2024-01-15 | Chinese | |
| 第四届董事会第二十一次会议决议公告 | 2024-01-15 | Chinese | |
| 关于2022年股票期权激励计划首次授予股票期权第一个行权期限制行权期间的提示性公告 | 2024-01-15 | Chinese | |
| 关于公司2024年度日常关联交易预计的公告 | 2024-01-15 | Chinese | |
| 关于2024年度为合作养殖农户提供担保预计的公告 | 2024-01-15 | Chinese | |
| 2024年第一次临时股东大会会议资料 | 2024-01-15 | Chinese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 38191206 | 关于召开2024年第一次临时股东大会的通知 | 2024-01-15 | Chinese | ||
| 38191180 | 第四届董事会第二十一次会议决议公告 | 2024-01-15 | Chinese | ||
| 38191167 | 关于2022年股票期权激励计划首次授予股票期权第一个行权期限制行权期间的提示性公告 | 2024-01-15 | Chinese | ||
| 38191151 | 关于公司2024年度日常关联交易预计的公告 | 2024-01-15 | Chinese | ||
| 38191126 | 关于2024年度为合作养殖农户提供担保预计的公告 | 2024-01-15 | Chinese | ||
| 38191109 | 2024年第一次临时股东大会会议资料 | 2024-01-15 | Chinese | ||
| 38191095 | 第四届董事会第一次独立董事专门会议决议 | 2024-01-15 | Chinese | ||
| 38191083 | 独立董事关于第四届董事会第二十一次会议相关议案的独立意见 | 2024-01-15 | Chinese | ||
| 38191065 | 关于2023年度为合作养殖农户提供担保预计的进展公告 | 2024-01-12 | Chinese | ||
| 38191052 | 关于回复上海证券交易所监管工作函的公告 | 2024-01-10 | Chinese | ||
| 38191025 | 关于累计涉及诉讼、仲裁事项的公告 | 2024-01-09 | Chinese | ||
| 38191012 | 关于收到《民事上诉状》暨诉讼进展公告 | 2024-01-09 | Chinese | ||
| 38190998 | 关于公司全资子公司涉及仲裁的进展公告 | 2024-01-03 | Chinese | ||
| 38190977 | 关于签订投资合作框架协议的公告 | 2024-01-02 | Chinese | ||
| 38190952 | 关于公司2023年度对外担保预计的进展公告 | 2024-01-02 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
TIANYU BIO-TECHNOLOGY CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57798/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57798 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57798 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57798 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57798}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TIANYU BIO-TECHNOLOGY CO.,LTD. (id: 57798)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.